Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction: A Prospective Cohort Study
Open Access
- 19 June 2024
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 134 (11) , 4614-4619
Abstract
Objectives: Retrograde Cricopharyngeal Dysfunction (RCPD) is treated by botulinum toxin (BTX) injection into the cricopharyngeus. This prospective study compares the effectiveness and side effects of operating room (OR) and in‐office (IO) injections.Methods: Patients over 18 years of age with inability to burp, abdominal, thoracic, or cervical gurgling sounds, bloating, and excessive flatulence were diagnosed with RCPD and included in the study. Injections were performed in the OR (80U) or IO (30U) by the senior author. An RCPD questionnaire quantifying major and minor symptoms on a Likert scale, Eating Assessment Tool‐10 (EAT‐10), and Generalized Anxiety Score−7 (GAD‐7), were completed preinjection; at 1, 2, and 3 weeks; and 3 months postoperatively. Linear mixed models were used to analyze effects of BTX injection on RCPD symptoms, the EAT‐10, and the GAD‐7.Results: 108 (55 M/53F) patients completed the pretreatment survey, 53 (31 OR vs. 22 IO) completed the 3‐week follow‐up, and 36 (22 OR vs. 14 IO) completed the 3‐month questionnaire. Average posttreatment RCPD scores were significantly lower in both groups at 3 weeks and 3 months (p < 0.0001), There was no difference between IO or OR (p = 0.4924). GAD‐7 scores were significantly lower in both groups at week 3 (p = 0.0018) and month 3 (p = 0.0012). Postinjection EAT‐10 scores were significantly higher in OR compared with IO (p = 0.0379).Conclusion: OR and IO injections are equally effective in the treatment of RCPD. Postinjection dysphagia is more severe after the OR injections which may be related to higher doses of BTX used. General anxiety levels decrease with treatment.Level of Evidence: 2 Laryngoscope, 134:4614–4619, 2024Keywords
This publication has 12 references indexed in Scilit:
- Experiences of Patients Living with Retrograde Cricopharyngeal DysfunctionThe Laryngoscope, 2023
- Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal DysfunctionThe Laryngoscope, 2023
- Retrograde Cricopharyngeus Dysfunction: The Jefferson ExperienceThe Laryngoscope, 2022
- “I've never been able to burp”: Preliminary description of retrograde cricopharyngeal dysfunction in childrenInternational Journal of Pediatric Otorhinolaryngology, 2022
- Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD)European Archives of Oto-Rhino-Laryngology, 2021
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and TreatmentOTO Open, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Validity and Reliability of the Eating Assessment Tool (EAT-10)Annals of Otology, Rhinology & Laryngology, 2008
- Dysfunction of the belch reflexGastroenterology, 1987